Dolasetron for the prevention of postoperative nausea and vomiting following outpatient surgery with general anaesthesia: A randomized, placebo-controlled study

European Journal of Anaesthesiology

Volumn 17, Issue 1, 2000, Pages 23-32

  Philip, B K ^{a,b,c,d,e,f,g,h,i,j,k}   Pearman, M H ^{a,b,c,d,e,f,g,h,i,j,k}   Kovac, A L ^{a,b,c,d,e,f,g,h,i,j,k}   Chelly, J E ^{a,b,c,d,e,f,g,h,i,j,k}   Wetchler, B V ^{a,b,c,d,e,f,g,h,i,j,k}   McKenzie, R ^{a,b,c,d,e,f,g,h,i,j,k}   Monk, T G ^{a,b,c,d,e,f,g,h,i,j,k}   Dershwitz, M ^{a,b,c,d,e,f,g,h,i,j,k}   Mingus, M ^{a,b,c,d,e,f,g,h,i,j,k}   Sung, Y F ^{a,b,c,d,e,f,g,h,i,j,k}   Hahne, W F ^{a,b,c,d,e,f,g,h,i,j,k}   Brown, R A ^{a,b,c,d,e,f,g,h,i,j,k}  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Baptist Medical Center   (United States)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e Methodist Medical Center of Illinois   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

^g WASHINGTON UNIVERSITY   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ Mount Sinai University   (United States)

^j EMORY CLINIC   (United States)

^k SANOFI   (France)

more..

Author keywords

5 HT3 antagonist; Anti emetic; Dolasetron; Emesis; Nausea; Outpatient surgery; Post operative complications; Post operative nausea and vomiting

Indexed keywords

DOLASETRON MESILATE; DROPERIDOL; METOCLOPRAMIDE; ONDANSETRON; SEROTONIN AGONIST;

ADOLESCENT; ADULT; ANTIEMETIC ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT SATISFACTION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE NAUSEA; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SURVIVAL TIME; VOMITING;

ADULT; AMBULATORY SURGICAL PROCEDURES; ANALYSIS OF VARIANCE; ANESTHESIA, GENERAL; ANTIEMETICS; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDOLES; INJECTIONS, INTRAVENOUS; LOGISTIC MODELS; MALE; PLACEBOS; POSTOPERATIVE NAUSEA AND VOMITING; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUINOLIZINES; REMISSION INDUCTION; SAFETY; SEX FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0034071676     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2346.2000.00594.x     Document Type: Article

References (18)

1. Bailey PL, Streisand JB, Pace NL et al. Transdermal scopolamine reduces nausea and vomiting after outpatient laparoscopy. Anesthesiology 1990; 72: 977-980.
2. Khalil SN, Kataria B, Pearson K et al. Ondansetron prevents postoperative nausea and vomiting in women outpatients. Anesth Analg 1994; 79: 845-851.
3. Larijani G, Gratz I, Afshar M, Minassian S. Treatment of postoperative nausea and vomiting with ondansetron: a randomized, double-blind comparison with placebo. Anesth Analg 1991; 73: 246-249.
4. Scuderi P, Wetchler B, Sung Y-F et al. Treatment of postoperative nausea and vomiting after outpatient surgery with the 5-HT3 antagonist ondansetron. Anesthesiology 1993; 78: 15-20.
5. Kovac AL, Pearman MH, Khalil SN et al. Ondansetron prevents postoperative emesis in male outpatients. J Clin Anesthesia 1996; 8: 644-651.
6. Lee PJ, Pandit SK, Green CR. Postanesthetic side effects in the outpatient - which are the most important? (abstract). Anesth Analg 1995; 80: S271.
7. van-Wijk MGF, Smalhout B. A postoperative analysis of the patient's view of anaesthesia in a Netherlands' teaching hospital. Anaesthesia 1990; 45: 679-682.
8. Watcha MF, White PF. Postoperative nausea and vomiting: its etiology, treatment, and prevention. Anesthesiology 1992; 77: 162-184.
9. Philip BK. Etiologies of postoperative nausea and vomiting. Pharm Therap 1997; 22: 18S-25S.
10. Audhuy B, Cappelaere P, Martin M et al. A double-blind, randomized comparison of the antiemetic efficacy of two intravenous doses of dolasetron and granisetron in patients receiving high-dose cisplatin chemotherapy. Eur J Cancer 1996; 32A: 807-813.
11. Harman GS, Omura GA, Ryan K, Hainsworth JD, Cramer MB, Hahne WF. A randomized, double-blind comparison of single-dose and divided multiple-dose dolasetron for cisplatin-induced emesis. Cancer Chemother Pharmacol 1996; 38: 323-328.
12. Kris MG, Grunberg SM, Gralla RJ et al. Dose-ranging evaluation of the serotonin antagonist dolasetron mesylate in patients receiving high-dose cisplatin. J Clin Oncol 1994; 12: 1045-1049.
13. Graczyk SG, McKenzie R, Kallar S et al. Intravenous dolasetron for the prevention of postoperative nausea and vomiting following outpatient laparoscopic gynecologic surgery. Anesth Analg 1997; 84: 325-330.
14. McKenzie R, Kovac A, O'Connor T et al. Comparison of ondansetron versus placebo to prevent postoperative nausea and vomiting in women undergoing ambulatory gynecologic surgery. Anesthesiology 1993; 78: 21-28.
15. Pearman MH. Single dose intravenous ondansetron in the prevention of postoperative nausea and vomiting. Anaesthesia 1994; 49 (Suppl.): 11-15.
16. Benedict CR, Arbogast R, Martin L, Patton L, Morrill B, Hahne W. Single-blind study of the effects of intravenous dolasetron mesylate versus ondansetron on electrocardiographic parameters in normal volunteers. J Cardiovasc Pharmacol 1996; 28: 53-59.
17. Jantunen IT, Kataja VV, Muhonen TT, Parviainen T. Effects of granisetron with doxorubicin or epirubicin on ECG intervals. Cancer Chemother Pharmacol 1996; 37: 502-504.
18. Lifsey DS, Gralla RJ, Clark RA, Kline RC. Electrocardiographic changes with serotonin antagonist anti-emetics: rate of occurrence and clinical relevance (abstract). Proc Am Soc Clin Oncol 1993; 12: 463.